Astera Labs, Inc.
ALAB
$120.31
$0.410.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 91.77% | 103.89% | 149.74% | 144.33% | 179.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 91.77% | 103.89% | 149.74% | 144.33% | 179.32% |
| Cost of Revenue | 80.39% | 117.24% | 172.78% | 171.62% | 218.98% |
| Gross Profit | 95.77% | 100.07% | 143.20% | 136.36% | 167.64% |
| SG&A Expenses | -8.49% | -10.05% | -11.44% | -45.49% | 361.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.46% | 43.60% | 50.35% | -0.05% | 239.69% |
| Operating Income | 46,398.61% | 722.82% | 263.36% | 113.60% | -98.40% |
| Income Before Tax | 637.39% | 3,216.57% | 459.72% | 127.01% | 0.07% |
| Income Tax Expenses | 342.19% | -352.39% | 91.43% | -180.29% | -285.87% |
| Earnings from Continuing Operations | 82.02% | 1,299.97% | 778.76% | 134.22% | 72.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.02% | 1,299.97% | 778.76% | 134.22% | 72.52% |
| EBIT | 46,398.61% | 722.82% | 263.36% | 113.60% | -98.40% |
| EBITDA | 6,143.65% | 806.75% | 274.21% | 115.07% | -88.31% |
| EPS Basic | 71.67% | 1,224.38% | 737.04% | 111.02% | -58.30% |
| Normalized Basic EPS | 596.17% | 3,020.00% | 437.57% | 108.70% | -75.84% |
| EPS Diluted | 83.67% | 1,100.00% | 680.00% | 110.17% | -63.15% |
| Normalized Diluted EPS | 622.02% | 2,791.25% | 413.58% | 107.96% | -78.21% |
| Average Basic Shares Outstanding | 6.01% | 6.76% | 6.59% | 210.66% | 313.77% |
| Average Diluted Shares Outstanding | 2.04% | 15.18% | 14.76% | 239.06% | 359.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |